Avidity Biosciences
RNAM
#1856
Rank
โ‚ฌ10.21 B
Marketcap
66,14ย โ‚ฌ
Share price
0.00%
Change (1 day)
52.70%
Change (1 year)

EPS for Avidity Biosciences (RNAM)

EPS in 2025 (TTM): -3,71ย โ‚ฌ

According to Avidity Biosciences's latest financial reports the company's current EPS (TTM) is -3,80ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -2,62ย โ‚ฌ.

EPS history for Avidity Biosciences from 2020 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-3,71ย โ‚ฌ41.31%
2024-2,62ย โ‚ฌ
2022-3,02ย โ‚ฌ-9.02%
2021-3,32ย โ‚ฌ68.93%
2020-1,97ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
0,64ย โ‚ฌ-116.99%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,61ย โ‚ฌ-168.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-2,39ย โ‚ฌ-37.08%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-1,19ย โ‚ฌ-68.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-0,95ย โ‚ฌ-74.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-45,70ย โ‚ฌ 1,103.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
1,64ย โ‚ฌ-143.30%๐Ÿ‡บ๐Ÿ‡ธ USA